Prestige Biopharma shareholders reappoint independent director Kyooho Bang

Prestige Biopharma’s annual shareholders’ meeting on 2026-09-29 adopted a resolution to reappoint independent director Kyooho Bang as an audit committee member, and delegated authority on auditor appointment, audit fees and share issuances.